1DOBBINS K R, PRICE F W J R, WHITSON W E. Trends in the indications forpenetrating keratoplasty in the midwestern United States [ J ]. Cornea, 2000,19:813 - 816.
4Huq S,Liu Y,Benichou G,et al.Relevance of the direct pathway of sensitization in corneal transplantation is dictated by the grift bed microenvironment.Immuno,2004,173:4464-469.
5Hamrah P,Liu Y,Zhang Q,et al.Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation.Arch Ophthalmol,2003,121:1132-1140.
2WOLLENSAK G, SPRL E, SEILER T. Riboflavin/ultraviolet -A - inducedcollagen cross - linking for the treatment of keratoconus [J]. Am J Ophthalmol,2003,135(5) :620 -627.
3CAPOROSSI A, BAIOCHI S, MAZZOTA C, et al . Parasurgical therapy for kereatoconus by riboflavin - ultraviolet type A rays in- duced cross - linking of corneal collagen : preliminary refractivere- suits in an Italian study [ J ]. Cat Ref Surg, 2006,32 ( 5 ) : 837 - 845.
4KOLLER T, MROCHEN M, SEILER T. Complication and failure rates after corneal crosslinking [ J ]. J CataractRefractSurg,2009,35 (8) :1358 - 1362.
